These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20926903)

  • 1. Recapitulation of ras oncogene mutations in breast cancer.
    Stamatakos M; Stefanaki C; Kontzoglou K; Masouridi S; Sakorafas G; Safioleas M
    Onkologie; 2010; 33(10):540-4. PubMed ID: 20926903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.
    Hollestelle A; Elstrodt F; Nagel JH; Kallemeijn WW; Schutte M
    Mol Cancer Res; 2007 Feb; 5(2):195-201. PubMed ID: 17314276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells.
    Weijzen S; Rizzo P; Braid M; Vaishnav R; Jonkheer SM; Zlobin A; Osborne BA; Gottipati S; Aster JC; Hahn WC; Rudolf M; Siziopikou K; Kast WM; Miele L
    Nat Med; 2002 Sep; 8(9):979-86. PubMed ID: 12185362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression and mutation of the ras family genes in human breast cancer.
    Miyakis S; Sourvinos G; Spandidos DA
    Biochem Biophys Res Commun; 1998 Oct; 251(2):609-12. PubMed ID: 9792821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biology of solid cancers: breast cancer as an example. Second part: gene disregulation in breast cancer].
    Bièche I; Lidereau R
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):142-52. PubMed ID: 8690862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning oncogenic ras-regulated genes by differential display.
    Jo H; Zhang H; Zhang R; Liang P
    Methods; 1998 Dec; 16(4):365-72. PubMed ID: 10049644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma.
    Ruíz-Godoy R LM; Garcia-Cuellar CM; Herrera González NE; Suchil BL; Pérez-Cárdenas E; Sácnchez-Pérez Y; Suárez-Roa ML; Meneses A
    J Exp Clin Cancer Res; 2006 Mar; 25(1):73-8. PubMed ID: 16761621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
    Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM
    Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mouse models of K-ras-initiated oncogenesis].
    Barrière C; Marjou FE; Louvard D; Robine S
    Bull Cancer; 2009 Dec; 96 Suppl():S5-14. PubMed ID: 20034865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
    Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
    Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profile associated with oncogenic ras-induced senescence, cell death, and transforming properties in human cells.
    Moumtzi SS; Roberts ML; Joyce T; Evangelidou M; Probert L; Frillingos S; Fotsis T; Pintzas A
    Cancer Invest; 2010 Jul; 28(6):563-87. PubMed ID: 19883200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
    Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
    Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of hepatocellular carcinoma.
    Wong CM; Ng IO
    Liver Int; 2008 Feb; 28(2):160-74. PubMed ID: 18069974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ras Rb1 and p53 proteins in human breast cancer.
    Spandidos DA; Karaiossifidi H; Malliri A; Linardopoulos S; Vassilaros S; Tsikkinis A; Field JK
    Anticancer Res; 1992; 12(1):81-9. PubMed ID: 1567185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene structure, function, and expression in breast cancer.
    Yee LD; Kacinski BM; Carter D
    Semin Diagn Pathol; 1989 May; 6(2):110-25. PubMed ID: 2669069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alternative H-ras protein p19 displays properties of a negative regulator of p21Ras.
    Huang MY; Cohen JB
    Oncol Res; 1997; 9(11-12):611-21. PubMed ID: 9563009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.